标题
Association between HMGB1 and COPD: A Systematic Review
作者
关键词
-
出版物
MEDIATORS OF INFLAMMATION
Volume 2015, Issue -, Pages 1-8
出版商
Hindawi Limited
发表日期
2015-12-22
DOI
10.1155/2015/164913
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- DAMPs and influenza virus infection in ageing
- (2015) Ramar Perumal Samy et al. AGEING RESEARCH REVIEWS
- High-mobility group box 1 promotes extracellular matrix synthesis and wound repair in human bronchial epithelial cells
- (2015) Oluwaseun O. Ojo et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Cigarette Smoke–Induced Damage-Associated Molecular Pattern Release from Necrotic Neutrophils Triggers Proinflammatory Mediator Release
- (2015) Irene H. Heijink et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Increased serum levels of LL37, HMGB1 and S100A9 during exacerbation in COPD patients
- (2015) Simon D. Pouwels et al. EUROPEAN RESPIRATORY JOURNAL
- High-mobility group box-1 induces vascular remodelling processesviac-Jun activation
- (2015) Diana Zabini et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Anti-Inflammatory Effects of Lactobacillus Rahmnosus and Bifidobacterium Breve on Cigarette Smoke Activated Human Macrophages
- (2015) Esmaeil Mortaz et al. PLoS One
- HMGB1 Develops Enhanced Proinflammatory Activity by Binding to Cytokines
- (2014) Y. Sha et al. JOURNAL OF IMMUNOLOGY
- High Mobility Group Box 1 Protein Binding to Lipopolysaccharide Facilitates Transfer of Lipopolysaccharide to CD14 and Enhances Lipopolysaccharide-Mediated TNF- Production in Human Monocytes
- (2014) J. H. Youn et al. JOURNAL OF IMMUNOLOGY
- HMGB1 in health and disease
- (2014) Rui Kang et al. MOLECULAR ASPECTS OF MEDICINE
- Innate immunity but not NLRP3 inflammasome activation correlates with severity of stable COPD
- (2014) Antonino Di Stefano et al. THORAX
- Soluble receptor for advanced glycation end-products and progression of airway disease
- (2014) Hiroshi Iwamoto et al. BMC Pulmonary Medicine
- Unknown
- (2013) Daolin Tang et al. MOLECULAR MEDICINE
- High expression of high-mobility group box 1 in the blood and lungs is associated with the development of chronic obstructive pulmonary disease in smokers
- (2013) Hsin-Kuo Ko et al. RESPIROLOGY
- Serum high mobility group box-1 is a powerful diagnostic and prognostic biomarker for pancreatic ductal adenocarcinoma
- (2012) Hye Won Chung et al. CANCER SCIENCE
- Effect of NF-κB inhibitor on high-mobility group protein B1 expression in a COPD rat model
- (2012) CHANG-MING WANG et al. Molecular Medicine Reports
- Validity of HMGB1 measurement in epithelial lining fluid in patients with COPD
- (2011) Hiroshi Kanazawa et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Unknown
- (2011) Changchun Hou et al. MOLECULAR MEDICINE
- Long-term exposure to cigarette smoke impairs lung function and increases HMGB-1 expression in mice
- (2011) Frank Silva Bezerra et al. RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY
- Expression of High-Mobility Group Box 1 and of Receptor for Advanced Glycation End Products in Chronic Obstructive Pulmonary Disease
- (2010) Nassima Ferhani et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Serum high mobility group box protein 1 as a clinical marker for non-small cell lung cancer
- (2009) Guan-Hong Shang et al. RESPIRATORY MEDICINE
- The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
- (2009) Alessandro Liberati et al. PLOS MEDICINE
- Potential Role of High-Mobility Group Box 1 in Cystic Fibrosis Airway Disease
- (2008) Steven M. Rowe et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- High-Mobility Group Box 1 Protein in Human and Murine Skin: Involvement in Wound Healing
- (2008) Stefania Straino et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More